Kintor Pharma

Kintor Pharma: Potential best-in-class androgen receptor (AR) antagonist that overcomes CNS tox and some of the other issues seen in SoC. Two Ph3s ongoing in China: Pivotal monotherapy and combo with abiraterone and a Ph2 ongoing in US for mCRPC (with breast and other AR-driven cancers behind). Additional pipeline includes a topical AR for alopecia and earlier-stage targets including ALK-1 and hedgehog.
Based in...
Clinical Stage
Phase III
Disease Space
COVID-19, Dermatology, Infectious Disease, Oncology
Market Cap
100MM - 500MM
Therapeutic Modalities
No.20 Songbei Road
Suzhou Industrial Park
Suzhou City, Jiangsu, 215123

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Grace Xie, IR
  • Lucy Lu, CFO

Upcoming Company Event Participation

Top 10 Holders of Kintor Pharmaceutical Ltd

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
CloudAlpha Capital Management Ltd. 5.88 22,778,000 268.78 Stakes 10/4/21
The Vanguard Group, Inc. 1.86 7,204,500 85.01 Funds 10/31/21
GF Fund Management Co., Ltd. 1.43 5,529,000 65.24 Funds 6/30/21
UBS Asset Management Switzerland AG 1.24 4,566,425 53.88 Stakes 5/31/21
China International Fund Management Co., Ltd. 0.29 1,125,000 13.28 Funds 6/30/21
E Fund Management Co., Ltd. 0.27 1,052,000 12.41 Funds 6/30/21
Invesco Hong Kong Ltd. 0.15 589,500 6.96 Funds 6/30/21
Norges Bank Investment Management 0.15 559,498 6.60 Funds 12/31/20
UBS Switzerland AG (Investment Management) 0.15 548,498 6.47 Stakes 5/27/21
CSOP Asset Management Ltd. 0.10 404,500 4.77 Funds 6/30/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.